Breaking News

Cambrex Expands Generic API R&D Capabilities

Will build new R&D lab at its Milan, Italy site

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Cambrex has unveiled plans to expand research and development capabilities at its site in Paullo, Milan, Italy. The investment will be in the construction of a new 150 square meter R&D laboratory and the recruitment of additional scientists to increase the number of generic APIs in the company’s development portfolio. The new laboratory will include 14 fume hoods and will combine both chemistry and analytical development capabilities, with the installation of glass lined reactors, a...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters